Kimberly-Clark Corporation (KMB) 10-Year Financial Performance & Capital Metrics

KMB • • Industrial / General

Consumer DefensiveHousehold ProductsBaby & Feminine CareBaby Care Products

AboutKimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.Show more

Revenue $20.06B -1.8%
EBITDA $3.99B +28.9%
Net Income $2.54B +44.3%
EPS (Diluted) 7.55 +44.9%
Gross Margin 35.8% +4.0%
EBITDA Margin 19.9% +31.3%
Operating Margin 16% +39.5%
Net Margin 12.69% +47.0%
ROE 249.14% +24.9%
ROIC 30.17% +45.1%
Debt/Equity 8.12 +6.9%
Interest Coverage 11.89 +48.6%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Dividend Aristocrat: 26 years of consecutive increases
✓Excellent 3Y average ROE of 239.3%
✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Healthy dividend yield of 4.9%
✓Healthy 5Y average net margin of 10.5%

✗Weaknesses

✗High debt to equity ratio of 8.1x
✗Weak momentum: RS Rating 17 (bottom 17%)
✗Trading more than 30% below 52-week high
✗Expensive at 34.1x book value

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y0.17%

5Y1.69%

3Y1.05%

TTM-10.13%

Profit (Net Income) CAGR

10Y5.25%

5Y3.36%

3Y11.95%

TTM-24.47%

EPS CAGR

10Y6.45%

5Y3.88%

3Y12.17%

TTM-23.35%

ROCE

10Y Avg29.26%

5Y Avg27.12%

3Y Avg26.37%

Latest32.17%

Peer Comparison

Baby Care Products

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
KMBKimberly-Clark Corporation	32.77B	98.73	13.08	-1.83%	10.9%	147.82%	7.67%	8.12

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	18.59B	18.2B	18.26B	18.49B	18.45B	19.14B	19.44B	20.18B	20.43B	20.06B
Revenue Growth %	-0.06%	-0.02%	0%	0.01%	-0%	0.04%	0.02%	0.04%	0.01%	-0.02%
Cost of Goods Sold+	11.97B	11.55B	11.71B	12.89B	12.41B	12.32B	13.45B	13.96B	13.4B	12.88B
COGS % of Revenue	0.64%	0.63%	0.64%	0.7%	0.67%	0.64%	0.69%	0.69%	0.66%	0.64%
Gross Profit+	6.62B	6.69B	6.59B	5.6B	6.04B	6.82B	5.99B	6.22B	7.03B	7.18B
Gross Margin %	0.36%	0.37%	0.36%	0.3%	0.33%	0.36%	0.31%	0.31%	0.34%	0.36%
Gross Profit Growth %	-0.01%	0.01%	-0.02%	-0.15%	0.08%	0.13%	-0.12%	0.04%	0.13%	0.02%
Operating Expenses+	5.01B	3.31B	3.23B	3.37B	3.04B	3.58B	3.43B	3.54B	4.69B	3.97B
OpEx % of Revenue	0.27%	0.18%	0.18%	0.18%	0.16%	0.19%	0.18%	0.18%	0.23%	0.2%
Selling, General & Admin	3.44B	2.97B	3.23B	3.37B	2.87B	3.25B	3.02B	3.29B	4.06B	4.31B
SG&A % of Revenue	0.19%	0.16%	0.18%	0.18%	0.16%	0.17%	0.16%	0.16%	0.2%	0.21%
Research & Development	324M	328M	309M	317M	284M	276M	269M	292M	312M	338M
R&D % of Revenue	0.02%	0.02%	0.02%	0.02%	0.02%	0.01%	0.01%	0.01%	0.02%	0.02%
Other Operating Expenses	1.24B	14M	-307M	-316M	-111M	55M	139M	-43M	320M	-679M
Operating Income+	1.61B	3.38B	3.36B	2.23B	2.99B	3.24B	2.56B	2.68B	2.34B	3.21B
Operating Margin %	0.09%	0.19%	0.18%	0.12%	0.16%	0.17%	0.13%	0.13%	0.11%	0.16%
Operating Income Growth %	-0.36%	1.1%	-0.01%	-0.34%	0.34%	0.08%	-0.21%	0.05%	-0.13%	0.37%
EBITDA+	2.36B	4.09B	4.08B	3.11B	3.91B	4.04B	3.33B	3.44B	3.1B	3.99B
EBITDA Margin %	0.13%	0.22%	0.22%	0.17%	0.21%	0.21%	0.17%	0.17%	0.15%	0.2%
EBITDA Growth %	-0.3%	0.73%	-0%	-0.24%	0.26%	0.03%	-0.18%	0.03%	-0.1%	0.29%
D&A (Non-Cash Add-back)	746M	705M	724M	882M	917M	796M	766M	754M	753M	781M
EBIT	1.63B	3.33B	3.31B	2.08B	2.91B	3.18B	2.48B	2.62B	2.31B	3.2B
Net Interest Income+	-278M	-308M	-308M	-253M	-250M	-244M	-250M	-268M	-227M	-222M
Interest Income	17M	11M	10M	10M	11M	8M	6M	14M	66M	48M
Interest Expense	295M	319M	318M	263M	261M	252M	256M	282M	293M	270M
Other Income/Expense	-278M	-374M	-367M	-416M	-341M	-314M	-336M	-341M	-323M	-283M
Pretax Income+	1.33B	3.01B	2.99B	1.81B	2.65B	2.93B	2.23B	2.34B	2.02B	2.93B
Pretax Margin %	0.07%	0.17%	0.16%	0.1%	0.14%	0.15%	0.11%	0.12%	0.1%	0.15%
Income Tax+	418M	922M	776M	471M	576M	676M	479M	495M	453M	565M
Effective Tax Rate %	0.76%	0.72%	0.76%	0.78%	0.81%	0.8%	0.82%	0.83%	0.87%	0.87%
Net Income+	1.01B	2.17B	2.28B	1.41B	2.16B	2.35B	1.81B	1.93B	1.76B	2.54B
Net Margin %	0.05%	0.12%	0.12%	0.08%	0.12%	0.12%	0.09%	0.1%	0.09%	0.13%
Net Income Growth %	-0.34%	1.14%	0.05%	-0.38%	0.53%	0.09%	-0.23%	0.07%	-0.09%	0.44%
Net Income (Continuing)	917M	2.09B	2.21B	1.34B	2.07B	2.25B	1.75B	1.84B	1.57B	2.36B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	214M	219M	253M	241M	227M	243M	223M	153M	153M	135M
EPS (Diluted)+	2.77	5.99	6.40	4.03	6.24	6.87	5.35	5.72	5.21	7.55
EPS Growth %	-0.31%	1.16%	0.07%	-0.37%	0.55%	0.1%	-0.22%	0.07%	-0.09%	0.45%
EPS (Basic)	2.78	6.03	6.44	4.05	6.28	6.90	5.38	5.73	5.21	7.58
Diluted Shares Outstanding	366.3M	361.7M	355.9M	349.6M	345.6M	342.5M	338.8M	338.3M	338.8M	337M
Basic Shares Outstanding	363.8M	359.4M	353.6M	348M	343.6M	340.7M	337.3M	337.4M	338.58M	337M
Dividend Payout Ratio	1.26%	0.61%	0.6%	0.98%	0.65%	0.62%	0.84%	0.81%	0.9%	0.64%

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	5.43B	5.12B	5.21B	5.04B	5.06B	5.17B	5.57B	5.73B	5.7B	5.58B
Cash & Short-Term Investments	619M	923M	616M	539M	442M	303M	270M	427M	1.09B	1.02B
Cash Only	619M	923M	616M	539M	442M	303M	270M	427M	1.09B	1.02B
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	2.28B	2.18B	2.31B	2.16B	2.26B	2.23B	2.21B	2.28B	2.13B	2.01B
Days Sales Outstanding	44.78	43.63	46.28	42.73	44.77	42.62	41.44	41.25	38.14	36.56
Inventory	1.91B	1.68B	1.79B	1.81B	1.79B	1.9B	2.24B	2.27B	1.96B	1.82B
Days Inventory Outstanding	58.23	53.05	55.81	51.34	52.63	56.39	60.75	59.34	53.26	51.64
Other Current Assets	617M	337M	490M	525M	562M	733M	849M	753M	520M	728M
Total Non-Current Assets+	9.42B	9.49B	9.94B	9.48B	10.23B	12.35B	12.27B	12.24B	11.64B	10.97B
Property, Plant & Equipment	7.1B	7.17B	7.44B	7.16B	7.45B	8.04B	8.1B	7.88B	7.91B	7.51B
Fixed Asset Turnover	2.62x	2.54x	2.46x	2.58x	2.48x	2.38x	2.40x	2.56x	2.58x	2.67x
Goodwill	1.45B	1.48B	1.58B	1.47B	1.47B	1.9B	1.84B	2.07B	2.08B	1.96B
Intangible Assets	94M	83M	0	0	29M	832M	810M	851M	197M	87M
Long-Term Investments	247M	257M	233M	224M	268M	300M	290M	238M	306M	314M
Other Non-Current Assets	525M	581M	695M	620M	1.01B	1.28B	1.24B	1.19B	1.14B	1.09B
Total Assets+	14.84B	14.6B	15.15B	14.52B	15.28B	17.52B	17.84B	17.97B	17.34B	16.55B
Asset Turnover	1.25x	1.25x	1.21x	1.27x	1.21x	1.09x	1.09x	1.12x	1.18x	1.21x
Asset Growth %	-0.04%	-0.02%	0.04%	-0.04%	0.05%	0.15%	0.02%	0.01%	-0.03%	-0.05%
Total Current Liabilities+	6.35B	5.85B	5.86B	6.54B	6.92B	6.44B	6.75B	7.33B	6.93B	7B
Accounts Payable	2.61B	2.61B	2.83B	3.19B	3.06B	3.34B	3.84B	3.81B	3.65B	3.71B
Days Payables Outstanding	79.67	82.44	88.37	90.34	89.82	98.85	104.19	99.72	99.51	105.29
Short-Term Debt	1.67B	1.13B	953M	1.21B	1.53B	486M	433M	844M	567M	552M
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	36M	44M	45M	0	0	0	397M	601M	494M	570M
Current Ratio	0.85x	0.87x	0.89x	0.77x	0.73x	0.80x	0.82x	0.78x	0.82x	0.80x
Quick Ratio	0.55x	0.59x	0.58x	0.49x	0.47x	0.51x	0.49x	0.47x	0.54x	0.54x
Cash Conversion Cycle	23.34	14.25	13.72	3.73	7.58	0.16	-2	0.87	-8.11	-17.09
Total Non-Current Liabilities+	8.45B	8.64B	8.41B	8.03B	8.17B	10.21B	10.35B	9.94B	9.35B	8.57B
Long-Term Debt	6.11B	6.44B	6.47B	6.25B	6.21B	7.88B	8.14B	7.58B	7.42B	6.88B
Capital Lease Obligations	0	0	0	0	0	0	0	0	0	358M
Deferred Tax Liabilities	766M	532M	395M	458M	511M	723M	694M	647M	374M	326M
Other Non-Current Liabilities	1.58B	1.67B	1.54B	1.32B	1.45B	1.61B	1.52B	1.71B	1.55B	1.02B
Total Liabilities	14.8B	14.48B	14.27B	14.56B	15.09B	16.65B	17.1B	17.27B	16.28B	15.57B
Total Debt+	7.78B	7.57B	7.42B	7.46B	7.88B	8.5B	8.7B	8.55B	8.11B	7.92B
Net Debt	7.16B	6.65B	6.81B	6.92B	7.43B	8.19B	8.43B	8.12B	7.02B	6.89B
Debt / Equity	194.38x	64.72x	8.42x	-	40.60x	9.78x	11.81x	12.21x	7.60x	8.12x
Debt / EBITDA	3.30x	1.85x	1.82x	2.40x	2.02x	2.10x	2.62x	2.49x	2.62x	1.98x
Net Debt / EBITDA	3.03x	1.63x	1.67x	2.22x	1.90x	2.03x	2.54x	2.36x	2.27x	1.73x
Interest Coverage	5.47x	10.61x	10.56x	8.48x	11.46x	12.87x	10.00x	9.51x	8.00x	11.89x
Total Equity+	40M	117M	882M	-46M	194M	869M	737M	700M	1.07B	975M
Equity Growth %	-0.96%	1.93%	6.54%	-1.05%	5.22%	3.48%	-0.15%	-0.05%	0.53%	-0.09%
Book Value per Share	0.11	0.32	2.48	-0.13	0.56	2.54	2.18	2.07	3.15	2.89
Total Shareholders' Equity	-174M	-102M	629M	-287M	-33M	626M	514M	547M	915M	840M
Common Stock	473M	473M	473M	473M	473M	473M	473M	473M	473M	473M
Retained Earnings	4.99B	5.83B	5.77B	5.95B	6.69B	7.57B	7.86B	8.2B	8.37B	9.26B
Treasury Stock	-2.97B	-3.63B	-3.29B	-3.96B	-4.45B	-4.9B	-5.18B	-5.14B	-5.22B	-5.99B
Accumulated OCI	-3.28B	-3.47B	-2.92B	-3.3B	-3.29B	-3.17B	-3.24B	-3.67B	-3.58B	-3.77B
Minority Interest	214M	219M	253M	241M	227M	243M	223M	153M	153M	135M

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	2.31B	3.23B	2.93B	2.97B	2.74B	3.73B	2.73B	2.73B	3.54B	3.23B
Operating CF Margin %	0.12%	0.18%	0.16%	0.16%	0.15%	0.19%	0.14%	0.14%	0.17%	0.16%
Operating CF Growth %	-0.19%	0.4%	-0.09%	0.01%	-0.08%	0.36%	-0.27%	0%	0.3%	-0.09%
Net Income	1.01B	2.17B	2.28B	1.41B	2.2B	2.4B	1.84B	1.96B	1.76B	2.58B
Depreciation & Amortization	746M	705M	724M	882M	917M	796M	766M	754M	753M	781M
Stock-Based Compensation	75M	77M	76M	41M	96M	147M	26M	150M	169M	131M
Deferred Taxes	-255M	-15M	-69M	2M	29M	45M	-70M	-57M	-322M	-38M
Other Non-Cash Items	1.17B	-35M	68M	246M	-215M	-18M	118M	-58M	609M	-396M
Working Capital Changes	-445M	334M	-148M	389M	-288M	363M	46M	-17M	569M	178M
Change in Receivables	60M	-23M	-44M	33M	-116M	95M	-37M	-151M	127M	48M
Change in Inventory	-28M	230M	-33M	-127M	24M	-96M	-417M	-76M	290M	10M
Change in Payables	44M	-61M	174M	392M	-153M	239M	627M	109M	-109M	179M
Cash from Investing+	-1.05B	-732M	-851M	-902M	-1.04B	-2.31B	-1.06B	-785M	-418M	-100M
Capital Expenditures	-1.06B	-771M	-785M	-877M	-1.21B	-1.22B	-1.01B	-876M	-766M	-721M
CapEx % of Revenue	0.06%	0.04%	0.04%	0.05%	0.07%	0.06%	0.05%	0.04%	0.04%	0.04%
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-1.07B	-727M	-820M	-821M	-1.02B	58M	-974M	-2M	253M	621M
Cash from Financing+	-1.3B	-2.19B	-2.42B	-2.12B	-1.79B	-1.57B	-1.7B	-1.76B	-2.37B	-3.17B
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	-1.27B	-1.31B	-1.36B	-1.39B	-1.41B	-1.45B	-1.52B	-1.56B	-1.59B	-1.63B
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	-15M	78M	33M	5M	114M	154M	-19M	-51M	-78M	15M
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	1.25B	2.46B	2.14B	2.09B	1.53B	2.51B	1.72B	1.86B	2.78B	2.51B
FCF Margin %	0.07%	0.14%	0.12%	0.11%	0.08%	0.13%	0.09%	0.09%	0.14%	0.13%
FCF Growth %	-0.31%	0.97%	-0.13%	-0.02%	-0.27%	0.65%	-0.31%	0.08%	0.49%	-0.09%
FCF per Share	3.41	6.80	6.02	5.99	4.42	7.33	5.09	5.49	8.19	7.46
FCF Conversion (FCF/Net Income)	2.28x	1.49x	1.29x	2.11x	1.27x	1.59x	1.50x	1.41x	2.01x	1.27x
Interest Paid	308M	315M	354M	264M	255M	245M	243M	270M	277M	268M
Taxes Paid	695M	744M	961M	395M	528M	533M	492M	468M	648M	587M

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	195%	2759.24%	456.06%	337.32%	2914.86%	442.52%	225.9%	269.17%	199.55%	249.14%
Return on Invested Capital (ROIC)	16.85%	36.35%	34.84%	22.96%	30.94%	29.15%	21.07%	22.35%	20.79%	30.17%
Gross Margin	35.63%	36.76%	36.08%	30.28%	32.71%	35.64%	30.8%	30.83%	34.42%	35.8%
Net Margin	5.45%	11.9%	12.48%	7.63%	11.69%	12.29%	9.33%	9.59%	8.63%	12.69%
Debt / Equity	194.38x	64.72x	8.42x	-	40.60x	9.78x	11.81x	12.21x	7.60x	8.12x
Interest Coverage	5.47x	10.61x	10.56x	8.48x	11.46x	12.87x	10.00x	9.51x	8.00x	11.89x
FCF Conversion	2.28x	1.49x	1.29x	2.11x	1.27x	1.59x	1.50x	1.41x	2.01x	1.27x
Revenue Growth	-5.74%	-2.09%	0.31%	1.24%	-0.19%	3.74%	1.57%	3.78%	1.27%	-1.83%

Revenue by Segment

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Consumer Tissue	6.12B	5.97B	5.93B	6.01B	5.99B	6.72B	6.03B	6.24B	6.29B	6.16B
Consumer Tissue Growth	-	-2.52%	-0.59%	1.40%	-0.37%	12.10%	-10.18%	3.46%	0.75%	-2.11%
Personal Care	9.2B	9.05B	9.08B	9.04B	9.11B	9.34B	10.27B	10.62B	10.69B	-
Personal Care Growth	-	-1.72%	0.35%	-0.45%	0.79%	2.54%	9.94%	3.46%	0.65%	-
K-C Professional	3.22B	3.15B	3.21B	3.38B	3.29B	3.02B	3.07B	3.26B	3.4B	-
K-C Professional Growth	-	-2.14%	1.84%	5.42%	-2.66%	-8.29%	1.76%	5.99%	4.55%	-

Revenue by Geography

	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024

Frequently Asked Questions

Valuation & Price

Kimberly-Clark Corporation (KMB) has a price-to-earnings (P/E) ratio of 13.1x. This may indicate the stock is undervalued or faces growth challenges.

Growth & Financials

Kimberly-Clark Corporation (KMB) reported $18.06B in revenue for fiscal year 2024. This represents a 13% decrease from $20.85B in 2011.

Kimberly-Clark Corporation (KMB) saw revenue decline by 1.8% over the past year.

Yes, Kimberly-Clark Corporation (KMB) is profitable, generating $1.97B in net income for fiscal year 2024 (12.7% net margin).

Dividend & Returns

Yes, Kimberly-Clark Corporation (KMB) pays a dividend with a yield of 4.89%. This makes it attractive for income-focused investors.

Kimberly-Clark Corporation (KMB) has a return on equity (ROE) of 249.1%. This is excellent, indicating efficient use of shareholder capital.

Kimberly-Clark Corporation (KMB) generated $2.41B in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

US Stock Screener

...